Sign In
Buy CLS
$331.44
-21.15 (-6.00%)
At Close: Jul 31, 2026
The Single Biggest Reason to Buy Celestica Ahead of July 27 Q2 Earnings
11:00am, Thursday, 23'rd Jul 2026
Celestica is reporting Q2 earnings on July 27, and the setup heading into that print raises a question most investors have not asked yet: what happens when a pick-and-shovel AI play trades at a discou
Celestica: A Stock to Watch in the AI Infrastructure Boom
07:00pm, Wednesday, 22'nd Jul 2026
Explore the exciting world of Celestica (CLS -1.20%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trend
Celestica (CLS) Sees a More Significant Dip Than Broader Market: Some Facts to Know
06:46pm, Wednesday, 22'nd Jul 2026
The latest trading day saw Celestica (CLS) settling at $335.5, representing a -1.2% change from its previous close.
Celestica to Release Q2 Earnings: How to Approach the Stock Now?
03:16pm, Wednesday, 22'nd Jul 2026
CLS nears Q2 earnings with AI infrastructure demand, cloud growth and healthcare traction in focus as estimates edge higher ahead of the report.
Celestica: The Market Just Started To Agree, And Q2 Isn't Priced Yet
12:45am, Wednesday, 22'nd Jul 2026
Celestica is upgraded to Buy, with improved 2027 revenue visibility and recent valuation corrections presenting an attractive entry ahead of Q2. Q1 established a ~$25.5b revenue floor for 2027, coveri
Celestica stock tumbles ahead of earnings: rebound or more pain?
09:16am, Tuesday, 21'st Jul 2026
Celestica stock has moved into a bear market, mirroring the performance of other artificial intelligence (AI) companies. CLS dropped to $307 in New York, down by over 35% from its highest level this y
Celestica Q2 Preview: The 1.6T Supercycle Meets The Overbuild Dilemma
08:00am, Tuesday, 21'st Jul 2026
Celestica is on a durable AI-driven growth path, but I see late-cycle risks and assign a Hold rating. CLS trades at 31x 2026 EPS guidance and 71x free cash flow, leaving little room for disappointment
Is Celestica (CLS) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:46pm, Monday, 20'th Jul 2026
Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Celestica (CLS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Monday, 20'th Jul 2026
Celestica (CLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why Celestica (CLS) is a Strong Growth Stock
10:45am, Monday, 20'th Jul 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Celestica: The Margin Supporting 35x Was Not There In 2023
09:26am, Thursday, 16'th Jul 2026
Celestica is well positioned in the AI hardware value chain, with HPS driving significant growth, but margins remain single-digit and value accrues upstream. HPS's share of revenue is set to rise from
Celestica (CLS) Stock Falls Amid Market Uptick: What Investors Need to Know
06:46pm, Wednesday, 15'th Jul 2026
In the most recent trading session, Celestica (CLS) closed at $334.77, indicating a -2.97% shift from the previous trading day.
Celestica: Expect Another Beat-And-Raise
05:48am, Tuesday, 14'th Jul 2026
Consensus forecasts Celestica's revenue growth accelerating from 55.55% to 57.24% YoY through FY26, supported by the 1.6T networking production ramp. Analysts issued 16 upward EPS revisions and 13 rev
Is Celestica (CLS) a Buy as Wall Street Analysts Look Optimistic?
10:32am, Monday, 13'th Jul 2026
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Celestica, Inc. (CLS) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 13'th Jul 2026
Celestica (CLS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
